fbpx

News & Press


US Representative Carolyn Maloney to Headline MRF Advocacy Days Plenary

February 23, 2022

WASHINGTON, DC (February 23, 2022) – The Melanoma Research Foundation (MRF) will host nearly 100 advocates during the all-virtual MRF Advocacy Days held March 7-11, 2022. U.S. Representative Carolyn B. Maloney (NY-12) will be featured as the program pl …



Out of the Shadows and “In the Sun”: Reflections from a Melanoma Survivor

February 22, 2022

Guest blog post by Monique Mack, “In the Sun” documentary participant, melanoma survivor and MRF advocate:   My name is Monique Mack, and I am honored to be an advocate for the Melanoma Research Foundation (MRF). I was recently in a documentary called …



Bringing Awareness of Sun Safety and Sun Care to the Black Community

February 22, 2022

Guest blog post by Katonya Breaux, Founder, Unsun Cosmetics and MRF advocate:   I discovered moles on my face that I thought were genetic, but after a visit to the dermatologist, I found they resulted from sun damage. The typical chemical sunscreens I …



Hope in the Ocular Melanoma Journey

February 17, 2022

Guest blog post by Samantha Buirski, ocular melanoma patient, advocate and member of the CURE OM Patient Steering Committee: Being part of a rare community is challenging. As humans we believe we are in control of our destinies and our future. When you …



The First FDA Approved Treatment for Metastatic Uveal Melanoma: What It Means for the OM Community

February 11, 2022

On January 26, 2022, the U.S. Food and Drug Administration announced the approval of KIMMTRAK (tebentafusp-tebn), the first and only FDA-approved treatment for metastatic uveal melanoma, developed by Immunocore. The approval follows Phase III clinical …